| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.9M | -31.8% |
| Cost of Revenue | $3.2M | -29.3% |
| Gross Profit | $635K | -42.3% |
| R&D Expense | $4.4M | -25.3% |
| SG&A Expense | $12.1M | +63.9% |
| Operating Income | -$23.0M | -176.0% |
| Interest Expense | $962K | +1256.5% |
| Pre-tax Income | -$38.1M | -28.3% |
| Income Tax | $20K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $38K | — |
| Accounts Receivable | $1.6M | +89.0% |
| Current Assets | $2.2M | +962.1% |
| Total Assets | $2.7M | -96.8% |
| Current Liabilities | $23.7M | +2375.0% |
| Long-term Debt | $2.5M | -71.4% |
| Total Liabilities | $26.2M | +69.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.1M | -494.9% |
| Capital Expenditures | $34K | — |
| Investing Cash Flow | -$34K | -100.0% |
| Financing Cash Flow | $15.1M | +109.5% |
| Free Cash Flow | -$18.1M | — |
| — |
| Net Income | -$38.1M | -4320.2% |
| EPS (Basic) | -$1.30 | +77.7% |
| EPS (Diluted) | -$1.30 | +77.7% |
| Stockholders' Equity |
| -$23.5M |
| -53.5% |